DOCSLIB.ORG

Regulation of Amino Acid Catabolism in Rats Fed Diets with Different Protein Content

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of Amino Acid Catabolism in Rats Fed Diets with Different Protein Content Regulation of amino acid catabolism in rats fed diets with different protein content Silvia Agnelli Aquesta tesi doctoral està subjecta a la llicència Reconeixement- NoComercial 3.0. Espanya de Creative Commons. Esta tesis doctoral está sujeta a la licencia Reconocimiento - NoComercial 3.0. España de Creative Commons. This doctoral thesis is licensed under the Creative Commons Attribution-NonCommercial 3.0. Spain License. UNIVERSITAT DE BARCELONA Regulation of amino acid catabolism in rats fed diets with different protein content Silvia Agnelli Barcelona, 2016 Alla mia Famiglia : per la pazienza e l'amore infinito i ii “Dubium sapientiae initium” René Descartes Meditationes de prima philosophia iii iv Abbreviations ATF:Activating transcription factor 4 AP-1:Activator protein-1 ARG:Arginase ASL:Argininosuccinate lyase ASS:Argininosuccinate synthase BAT:Brown adipose tissue BCAA:Branched-chain amino acids BiP:Immunoglobulin binding protein BMI:Body mass index CAFD:Cafeteria diet CPS:Carbamoyl-phosphate synthase DAG:Diacylglicerol eIF2α:Eukaryotic translation initiation factor 2 eNOS:Vascular endothelial constitutive NOS ER:Endoplasmic reticulum GADD34:Growth arrest and DNA damage- inducible protein GLUT-4:Glucose transporter 4 GOT:Glutamic oxaloacetic transaminase GPT:Glutamate-pyruvate transaminase HDL:High density lipoprotein HFD:High fat diet HPD:High protein diet IKK:Inhibitor of κ kinase IL:Interleukin IMCL:Intramyocellular lipid iNOS:Inducibile NOS IR:Insulin resistance IRE1:Inositol requiring 1 IRS:Insulin receptor substrate JNK:c-jun N-terminal kinase LPS:Lipopolisaccharide MS:Metabolic sindrome NAFLD:Non-alcoholic fatty liver disease v NF-κB:Nuclear factor -light-chain-enhancer of activated cells nNOS:Neuronal or brain constitutive NOS NO·:Nitric oxide NOS:Nitric oxide synthase NRF2:Nuclear factor erythroid 2 OTC:Ornithine transcarbamylase PERK:PKR-like ER kinase PKC:Protein kinase C PP1:Protein phosphatase 1 SCFA:Short chain fatty acids SDH:Serine dehydratase SFA:Saturated fatty acid T2DM:Type 2 diabetes mellitus TAG:Triacylglycerol TLR:Tool-like receptor TNFα:Tumor necrosis factor TRAF2:Tumor necrosis factor receptor-associated factor 2 UC:Urea cycle UPR:Unfolded protein response VLDL:Very low-density lipoprotein WAT:White adipose tissue WHO:World Health Organization XBP1:X box-binding protein 1 vi Abstract Current lifestyle with high-energy diets and characterized by sedentary is triggering an alarming growth in obesity. Obesity along with metabolic syndrome-related co-morbidities (i.e. insulin resistance, atherosclerosis, sleep apnoea, depression, asthma, hypertension and the alteration of blood lipid transport) are the most apparent consequence of the excess energy. Under conditions of excess dietary energy, the body cannot easily dispose of the excess amino-N against the evolutively-adapted schemes that prevent its wastage; thus ammonia and glutamine formation and urea excretion are decreased. High lipid and energy availability limit the utilisation of glucose, and high glucose spares the production of ammonium from amino acids, decreasing the synthesis of glutamine and its utilisation by the intestine and kidney. In contrast, high protein diets enhance protein synthesis and growth, and the synthesis of non-protein- N-containing compounds. But these outlets are not enough; consequently, less-conventional mechanisms are activated, such as increased synthesis of NO∙followed by higher nitrite (and nitrate) excretion and changes in the microbiota. In this study we studied how the initial phase of development of metabolic syndrome can affects the function of liver as main site of amino-N metabolism, and to determine whether doubling the protein content in the diet induced significant changes in enzyme of amino acids metabolism along intestine and on liver. The common result obtained by these studies is that, both in case of hyperlipidic or hyperproteic diets, elimination of excess N is necessary but cannot be easily carried out through the metabolic pathways/tissues we evaluated, although possible alternative pathways have been taken into consideration. vii viii Contents 1. INTRODUCTION ............................................................................................................. 1 1.1 The metabolic syndrome ................................................................................................. 3 1.1.1 The insulin resistance ................................................................................................. 5 1.1.2 Obesity and high fat diets ......................................................................................... 17 1.2 Amino-N disposal in metabolic syndrome ................................................................... 20 1.3 High protein diets and their differences with high fat diets ...................................... 22 1.4 Outline of nitrogen metabolism .................................................................................... 24 2. OBJECTIVES ................................................................................................................. 39 3. METHODS...................................................................................................................... 43 3.1 Development of methods for the determination of ornithine carbamoyl transferase and argininosuccinate synthase activities in rat tissues ............................................. 44 4. RESULTS ........................................................................................................................ 63 4.1 Sabater D, Agnelli S, Arriarán S, et al. Altered nitrogen balance and decreased urea excretion in male rats fed cafeteria diet are related to arginine availability. Biomed Res. Int. 2014, 959420 (2014) .......................................................................... 64 ix 4.2 Agnelli S, Arriarán S, Oliva L, et al. Modulation of rat liver urea cycle and related ammonium metabolism by sex and cafeteria diet. RSC Adv 6, 11278–11288 (2016) ......................................................................................................................................... 74 4.3 Sabater D, Agnelli S, Arriarán S, et al. Cafeteria diet induce changes in blood flow that are more related with heat dissipation than energy accretion. PeerJ 4, e2302 (2016) ............................................................................................................................... 86 4.4 Agnelli S, Arriarán S, Fernández-López JA, et al. The activity of amino acid metabolism enzymes along the small intestine of male rats is slightly affected by high-protein diet. Under evaluation (European Journal of Nutrition) ..................... 98 4.5 Agnelli S, Arriarán S, Fernández-López JA, et al. The effects of high-protein diet on amino acid metabolism of lean and obese Zucker rats. Under evaluation (Food&Function) ......................................................................................................... 118 5. GENERAL DISCUSSION ........................................................................................... 137 6. SUMMARY ................................................................................................................... 145 7. CONCLUSIONS ........................................................................................................... 149 8. BIBLIOGRAPHY ......................................................................................................... 153 x List of tables and figures Table 1. Names given to the clustering of metabolic syndrome disorders. .................................. 4 Figure 1. Insulin Action. .................................................................................................................... 6 Figure 2. Lipid accumulation in adipose and non-adipose tissues ................................................ 8 Figure 3. Molecular mechanisms of skeletal muscle insulin resistance ........................................ 9 Figure 4. Hallmarks of metabolic inflammation in adipocyte ..................................................... 12 Figure 5. Diet-induced dysbiosis affects disease susceptibility .................................................... 16 Figure 6. Schematic representation of amino acid catabolism in mammals .............................. 25 Figure 7. The transamination reaction catalyzed by alanine aminotransferase. ....................... 26 Figure 8. Glutamate dehydrogenase reaction................................................................................ 27 Figure 9. Glutamine synthetase reaction. ...................................................................................... 28 Figure 10. Schematic representation of mechanism of action of L- glutaminase. ..................... 29 Figure 11. The enzymatic reaction of serine dehydratase. ........................................................... 29 Figure 12. The enzymatic reaction of AMP deaminase. ............................................................... 29 Figure 13. The enzymatic reaction catalyzes by glycine cleavage system. .................................. 30 Figure 14. The enzymatic reaction catalyzed by monoamine oxidase. ....................................... 31 xi Figure 15. Mechanism of chemical reaction catalyzed by L-amino acid oxidases. .................... 32 Figure 16. Schematic representation of urea cycle. ...................................................................... 34 xii Introduction 1. INTRODUCTION 1 Introduction 2
Load more

Recommended publications
  • Characterization of L-Serine Deaminases, Sdaa (PA2448) and Sdab 2 (PA5379), and Their Potential Role in Pseudomonas Aeruginosa 3 Pathogenesis 4 5 Sixto M
    bioRxiv preprint doi: https://doi.org/10.1101/394957; this version posted August 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Characterization of L-serine deaminases, SdaA (PA2448) and SdaB 2 (PA5379), and their potential role in Pseudomonas aeruginosa 3 pathogenesis 4 5 Sixto M. Leal1,6, Elaine Newman2 and Kalai Mathee1,3,4,5 * 6 7 Author affiliations: 8 9 1Department of Biological Sciences, College of Arts Sciences and 10 Education, Florida International University, Miami, United States of 11 America 12 2Department of Biological Sciences, Concordia University, Montreal, 13 Canada 14 3Department of Molecular Microbiology and Infectious Diseases, Herbert 15 Wertheim College of Medicine, Florida International University, Miami, 16 United States of America 17 4Biomolecular Sciences Institute, Florida International University, Miami, 18 United States of America 19 20 Present address: 21 22 5Department of Human and Molecular Genetics, Herbert Wertheim 23 College of Medicine, Florida International University, Miami, United States 24 of America 25 6Case Western Reserve University, United States of America 26 27 28 *Correspondance: Kalai Mathee, MS, PhD, 29 [email protected] 30 31 Telephone : 1-305-348-0628 32 33 Keywords: Serine Catabolism, Central Metabolism, TCA Cycle, Pyruvate, 34 Leucine Responsive Regulatory Protein (LRP), One Carbon Metabolism 35 Running title: P. aeruginosa L-serine deaminases 36 Subject category: Pathogenicity and Virulence/Host Response 37 1 bioRxiv preprint doi: https://doi.org/10.1101/394957; this version posted August 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • Isolation and Nucleotide Sequence of the Cdna for Rat Liver Serine
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 5809-5813, August 1988 Biochemistry Isolation and nucleotide sequence of the cDNA for rat liver serine dehydratase mRNA and structures of the 5' and 3' flanking regions of the serine dehydratase gene (threonine dehydratase/hormonal regulation/consensus sequences) HIROFUMI OGAWA*t, DUNCAN A. MILLER*, TRACY DUNN*, YEU SU*, JAMES M. BURCHAMt, CARL PERAINOt, MOTOJI FUJIOKAt, KAY BABCOCK*, AND HENRY C. PITOT*§ *McArdle Laboratory for Cancer Research, The Medical School, University of Wisconsin, Madison, WI 53706; tDepartment of Biochemistry, Toyama Medical and Pharmaceutical University, Faculty of Medicine, Sugitani, Toyama 930-01, Japan; and tDivision of Biological and Medical Research, Argonne National Laboratory, Argonne, IL 60439 Communicated by Van R. Potter, April 15, 1988 (received for review December 29, 1987) ABSTRACT Rat serine dehydratase cDNA clones were determination of the exact size of DNA complementary to isolated from a Agtll cDNA library on the basis of their serine dehydratase mRNA was made by S1 nuclease and reactivity with monospecific immunoglobulin to the purified sequencing of genomic clones of the regions flanking the enzyme. Using the cDNA insert from a clone that encoded the gene. serine dehydratase subunit as a probe, additional clones were isolated from the same library by plaque hybridization. Nucle- otide sequence analysis of the largest clone obtained showed MATERIALS AND METHODS that it has 1444 base pairs with an open reading frame consisting of 1089 base pairs. The deduced amino acid sequence cDNA Cloning. A rat liver cDNA library constructed in contained sequences of several portions of the serine dehydra- Agtll phage (13) was screened for antibody-reactive plaques tase protein, as determined by Edman degradation.
    [Show full text]
  • Spell Checked 12-13 BP Cards 52-113 Layout 1
    Provide a detoxification mechanism Deamination is also an oxidative reaction that occurs under aerobic conditions in all tissues but especially the liver and kidneys. During oxidative deamination, an amino acid is converted into the corresponding keto acid (for energy) by the removal of the amine functional group as ammo- nia and the amine functional group is replaced by the ketone group. The ammonia eventually goes into the urea cycle. Oxidative deamination occurs primarily on glutamic acid because glutamic acid was the end product of many transamination reactions. Glutamate dehydrogenase is an enzyme of the oxidoreductase class that catalyzes the oxidative deamination of glutamate. Ammonia is released, and α-ketoglutarate is formed. Glutamate dehydrogenase is unusual in that it can use either NAD or NADP as a coenzyme. The reversible reaction has a major function in both the synthesis and degradation of glutamic acid and, via transaminases, other amino acids as well. *** Important: Both aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are transaminases (aminotransferases). They are not involved in oxidative deamination reactions. In contrast to transamination reactions that transfer amino groups, oxidative deamination results in the liberation of the amino group as free ammonia. 1. Glutaminase deaminates glutamine to glutamate and ammonium ion; asparagin- Notes ase deaminates asparagine to aspartate and ammonium ion. 2. Glutamate is unique in that it is the only amino acid that undergoes rapid oxidative deamination. + 3. Histidine is deaminated by histidase to form ammonium ion (NH 4) and urocan- ate. 4. Serine and threonine are deaminated by serine dehydratase. Serine is converted to pyruvate, and threonine to α-ketobutyrate (which is decarboxylated oxidatively to form propionyl CoA); ammonium ion is released..
    [Show full text]
  • Letters to Nature
    letters to nature Received 7 July; accepted 21 September 1998. 26. Tronrud, D. E. Conjugate-direction minimization: an improved method for the re®nement of macromolecules. Acta Crystallogr. A 48, 912±916 (1992). 1. Dalbey, R. E., Lively, M. O., Bron, S. & van Dijl, J. M. The chemistry and enzymology of the type 1 27. Wolfe, P. B., Wickner, W. & Goodman, J. M. Sequence of the leader peptidase gene of Escherichia coli signal peptidases. Protein Sci. 6, 1129±1138 (1997). and the orientation of leader peptidase in the bacterial envelope. J. Biol. Chem. 258, 12073±12080 2. Kuo, D. W. et al. Escherichia coli leader peptidase: production of an active form lacking a requirement (1983). for detergent and development of peptide substrates. Arch. Biochem. Biophys. 303, 274±280 (1993). 28. Kraulis, P.G. Molscript: a program to produce both detailed and schematic plots of protein structures. 3. Tschantz, W. R. et al. Characterization of a soluble, catalytically active form of Escherichia coli leader J. Appl. Crystallogr. 24, 946±950 (1991). peptidase: requirement of detergent or phospholipid for optimal activity. Biochemistry 34, 3935±3941 29. Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and (1995). the thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281±296 (1991). 4. Allsop, A. E. et al.inAnti-Infectives, Recent Advances in Chemistry and Structure-Activity Relationships 30. Meritt, E. A. & Bacon, D. J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505± (eds Bently, P. H. & O'Hanlon, P. J.) 61±72 (R. Soc. Chem., Cambridge, 1997).
    [Show full text]
  • Characterization of an L-Serine Dehydratase Activity in Permeabilized Cells of Brevibacterium Linens ATCC 9175 Dominique Hamouy, M
    Characterization of an L-serine dehydratase activity in permeabilized cells of Brevibacterium linens ATCC 9175 Dominique Hamouy, M. J. Desmazeaud To cite this version: Dominique Hamouy, M. J. Desmazeaud. Characterization of an L-serine dehydratase activity in permeabilized cells of Brevibacterium linens ATCC 9175. Le Lait, INRA Editions, 1985, 65 (649_650), pp.103-121. hal-00929050 HAL Id: hal-00929050 https://hal.archives-ouvertes.fr/hal-00929050 Submitted on 1 Jan 1985 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Le Lait (1985), 65 (649-650), 103-121 Characterization of an L-serine dehydratase activity in permeabilized cells of Brevibacterium linens ATCC 9175 Dominique HAMOUY and M. J. DESMAZEAUD* SUMMARV Brevibacterium linens ATCC 9175 praduces large quantities of, ammonia and pyruvate [rom L-serine. This reaction occurs via an L-serine dehydratase (EC.4.2.I.13), whose activity is maximal at the end of exponential growth on rich medium and which abruptly decreases at the beginning of the stationary phase. ft is not possible ta extract the soluble form of the enzyme without a total loss of activity. Subcellular localization studies after creating stable proto- plasts with lysozyme have shawn that a part of the activity is bound ta cell membranes.
    [Show full text]
  • Systematic Manipulation of Glutathione Metabolism in Escherichia Coli for Improved Glutathione Production
    Zhang et al. Microb Cell Fact (2016) 15:38 DOI 10.1186/s12934-016-0439-1 Microbial Cell Factories RESEARCH Open Access Systematic manipulation of glutathione metabolism in Escherichia coli for improved glutathione production Jing Zhang1, Cong Quan1, Cheng Wang1, Hui Wu1*, Zhimin Li1,2* and Qin Ye1 Abstract Background: L-glutathione (GSH) is a non-protein thiol compound with important biological properties and is widely used in pharmaceutical, food, cosmetic and health products. The cellular GSH is determined by the activity and characteristic of GSH-synthesizing enzymes, energy and precursor supply, and degradation of formed GSH. Results: In this study, genes encoding enzymes related to the precursor amino acid degradation and glycogen formation as well as GSH degradation were systematically manipulated in Escherichia coli strains over-expressing gshF from Actinobacillus succinogenes. The manipulation included disrupting the precursor degradation pathways (tnaA and sdaA), eliminating L-glutathione degradation (ggt and pepT), and manipulating the intracellular ATP level (disrup- tion of glgB). However the constructed mutants showed lower levels of GshF expression. 2-D electrophoresis was per- formed to elucidate the reasons for this discrepancy, and the results indicated obvious changes in central metabolism and amino acid metabolism in the penta-mutant. Fed-batch culture of the penta-mutant ZJ12345 was performed where the GshF expression level was enhanced, and both the GSH production (19.10 mM) and the yield based on added L-cysteine (0.76 mmol/mmol) were significantly increased. Conclusion: By interrupting the degradation pathways of L-cysteine, serine and GSH and blocking glycogen forma- tion, the GSH production efficiency was significantly improved.
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION Pyridoxal 5’-phosphate (hydrate) Item No. 20352 CAS Registry No.: 853645-22-4 Formal Name: 3-hydroxy-2-methyl-5-[(phosphonooxy) HO O methyl]-4-pyridinecarboxaldehyde, hydrate MF: C H NO P • XH O P 8 10 6 2 HO O N FW: 265.2 Purity: ≥95% • XH2O O UV/Vis.: λmax: 295, 388 nm A crystalline solid Supplied as: H OH Storage: Room temperature Stability: ≥2 years Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures Pyridoxal 5’-phosphate (hydrate) is supplied as a crystalline solid. Aqueous solutions of pyridoxal 5’-phosphate (hydrate) can be prepared by directly dissolving the crystalline solid in aqueous buffers. The solubility of pyridoxal 5’-phosphate (hydrate) in PBS, pH 7.2, is approximately 1 mg/ml. We do not recommend storing the aqueous solution for more than one day. Description Pyridoxal 5’-phosphate, the active form of vitamin B6, is a cofactor for many different enzymes involved in transamination reactions, including mitochondrial cysteine desulfurase, cystathionine γ-synthase, various aminotransferases, and D-serine dehydratase. It has been used to study the pyridoxal 5’-phosphate-dependent active sites of these enzymes.1-4 References 1. Zhu, W., Lin, A., and Banerjee, R. Kinetic properties of polymorphic variants and pathogenic mutants in human cystathionine γ-lyase. Biochemistry 47, 6226-6232 (2008). 2. Steegborn, C., Clausen, T., Sondermann, P., et al. Kinetics and inhibition of recombinant human cystathionine γ-lyase. Toward the rational control of transsulfuration. J. Biol. Chem. 274(18), 12675-12684 (1999). 3. Goto, M., Miyahara, I., Hayashi, H., et al.
    [Show full text]
  • A Review of Isozymes in Cancer1
    Cancer Research VOLUME31 NOVEMBER 1971 NUMBER11 [CANCER RESEARCH 31, 1523-1542, November 1971] A Review of Isozymes in Cancer1 Wayne E. Criss Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32601 TABLE OF CONTENTS postulated role for that particular isozymic system in cellular metabolism. Summary 1523 Introduction 1523 Normal enzyme differentiation 1523 INTRODUCTION Tumor enzyme differentiation 1524 Isozymes 1524 Normal Enzyme Differentiation DNA polymerase 1524 Enzyme differentiation is the process whereby, during the Hexokinase 1525 Fructose 1,6-diphosphatase 1525 development of an organ in an animal, the organ acquires the quantitative and qualitative adult enzyme patterns (122). Key Aldolase 1526 pathway enzymes in several metabolic processes have been Pyruvate kinase 1527 found to undergo enzymatic differentiation. The enzymes Láclatedehydrogenase 1527 Isocitrate dehydrogenase 1527 involved in nitrogen metabolism, and also in urea cycle Malate dehydrogenase 1528 metabolism (180), are tyrosine aminotransferase (123, 151, Glycerol phosphate dehydrogenase 1529 330, 410), tryptophan pyrrolase (261), serine dehydratase Glutaminase 1529 (123, 410), histidine ammonia lyase (11), and aspartate Aspartate aminotransferase 1530 aminotransferase (337, 388). The enzymes involved in nucleic Adenylate kinase 1531 acid metabolism are DNA polymerase (156, 277) and RNase (52). In glycolysis the enzymes are hexokinase-glucokinase Carbamyl phosphate synthetase 1531 Lactose synthetase 1533 (98, 389), galactokinase 30, aldolase (267, 315), pyruvate Discussion 1533 kinase (73, 386), and lactate dehydrogenase (67, 69). In References 1533 mitochondrial oxidation they are NADH oxidase, succinic oxidase, a-glycero-P oxidase, ATPase, cytochrome oxidase, and flavin content (84, 296). In glycogen metabolism the SUMMARY enzymes involved are UDPG pyrophosphorylase and UDPG glucosyltransferase (19).
    [Show full text]
  • WO 2017/083351 Al 18 May 2017 (18.05.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/083351 Al 18 May 2017 (18.05.2017) P O P C T (51) International Patent Classification: MCAVOY, Bonnie D.; 110 Canal Street, Lowell, Mas- C12N 1/20 (2006.01) A01N 41/08 (2006.01) sachusetts 01854 (US). C12N 1/21 (2006.01) C07C 403/24 (2006.01) (74) Agent: JACOBSON, Jill A.; FisherBroyles, LLP, 2784 C12N 15/75 (2006.01) A23L 33/175 (2016.01) Homestead Rd. #321, Santa Clara, California 9505 1 (US). A23K 10/10 (2016.01) A23L 5/44 (2016.01) (81) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of national protection available): AE, AG, AL, AM, PCT/US20 16/06 1081 AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (22) International Filing Date: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, ' November 2016 (09.1 1.2016) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (25) Filing Language: English KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (26) Publication Language: English MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (30) Priority Data: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, 62/252,971 ' November 2015 (09.
    [Show full text]
  • Methionine Metabolism in Humans: New Perspectives on Epigenetic
    a ular nd G ec en l e o t i M c f M o l e Journal of Molecular and Genetic d a i n c r i n u e o Venkatachalam, J Mol Genet Med 2014, 8:4 J Medicine ISSN: 1747-0862 DOI: 10.4172/1747-0862.1000138 Review Article Open Access Methionine Metabolism in Humans: New Perspectives on Epigenetic Inheritance Venkatachalam KV* College of Medical Sciences, Nova Southeastern University, USA *Corresponding author: Venkatachalam KV, Professor of Biochemistry, College of Medical Sciences, Nova Southeastern University, Ft. Lauderdale, FL-33328, USA, Tel: (954)262-1335; E-mail: [email protected] Rec date: August 13, 2014; Acc date: October 14, 2014; Pub date: October 16, 2014 Copyright: © 2014 Venkatachalam KV. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Epigenetic control by methylation is directly dependent on SAM/methionine. Free methionine aside from being used for protein synthesis is activated to universal methyl group donor SAM and the methyl group from it can be transferred mainly onto DNA, histones, mRNA and noncoding (Nc) RNA, in the nucleus and onto various cytosolic recipients by specific methyltransferases. The product S-adenosylhomocysteine (SAH) from methyltransferase reaction is cleaved into free homocysteine and adenosine. Homocysteine has two fates, one to enter methionine re- synthesis which requires methionine synthase (MetS), the coenzymes N5-methyltetrahydrofolate (vitamin B9) and methylcobalamin (vitamin B12). The second option of homocysteine is to enter cysteine synthesis pathway which requires cystathionine -synthase (CBS), serine, vitamin B6 (pyridoxal phosphate) and cystathionine γ-lyase (CGL).
    [Show full text]
  • Serine Dehydratase from Legionella Pneumophila: Novel Use of the C‑Terminal Cysteine As an Intrinsic Competitive Inhibitor † † ‡ James B
    Article pubs.acs.org/biochemistry Structure of L‑Serine Dehydratase from Legionella pneumophila: Novel Use of the C‑Terminal Cysteine as an Intrinsic Competitive Inhibitor † † ‡ James B. Thoden, Hazel M. Holden,*, and Gregory A. Grant*, † Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706, United States ‡ Department of Developmental Biology and Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, United States ABSTRACT: Here we report the first complete structure of a bacterial Fe−S L- serine dehydratase determined to 2.25 Å resolution. The structure is of the type 2 L- serine dehydratase from Legionella pneumophila that consists of a single polypeptide chain containing a catalytic α domain and a β domain that is structurally homologous to the “allosteric substrate binding” or ASB domain of D-3-phosphoglycerate dehydrogenase from Mycobacterium tuberculosis. The enzyme exists as a dimer of identical subunits, with each subunit exhibiting a bilobal architecture. The [4Fe-4S]2+ cluster is bound by residues from the C-terminal α domain and is situated between this domain and the N-terminal β domain. Remarkably, the model reveals that the C- terminal cysteine residue (Cys 458), which is conserved among the type 2 L-serine dehydratases, functions as a fourth ligand to the iron−sulfur cluster producing a “tail in mouth” configuration. The interaction of the sulfhydryl group of Cys 458 with the fourth iron of the cluster appears to mimic the position that the substrate would adopt prior to catalysis. A number of highly conserved or invariant residues found in the β domain are clustered around the iron−sulfur center.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]